Close Menu

NEW YORK — The US Food and Drug Administration on Monday granted Emergency Use Authorization for 1drop's PCR-based SARS-CoV-2 test.

The 1copy COVID-19 qPCR Multi Kit is designed to detect the E and RdRp genes of SARS-CoV-2 in nasopharyngeal, oropharyngeal, anterior nasal, and midturbinate nasal swab specimens, as well as nasopharyngeal wash/aspirates and nasal aspirate specimens. According to South Korea-based 1drop, the test provides results within two hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Nov
10
Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.